was one of the most influential and forward-thinking scientists of the past 50 years. The discovery of brain stimulation reward by Jim Olds and Peter Milner in 1954 provided a significant boost to the hypothesis that there were neural systems in the brain that mediated positive reinforcement, but it was the seminal work of Larry Stein that linked brain stimulation reward to specific neurochemical systems, notably catecholamines. Dr. Stein discovered that amphetamine, a catecholamine-enhancing drug, facilitated self-stimulation behavior by lowering the threshold current intensity for brain stimulation reinforcement. He also showed that brain stimulation not only could serve as a primary reinforcer but also could establish secondary reinforcing powers to previously neutral stimuli (process of conditioned reinforcement), further supporting the hypothesis that brain stimulation reward tapped into neurocircuitry that mediated natural reinforcement. Linking the observation that dopamine and norepinephrine fibers ascend in the brain via the lateral hypothalamic medial forebrain bundle and the observation that this pathway generated the highest rates of self-stimulation, Dr. Stein hypothesized that positive reinforcement, also termed reward, was mediated by brain catecholamine systems. Furthermore, he demonstrated that amphetamines worked via the indirect release of catecholamines. This hypothesis and its explanation for the behavioral effects of psychostimulants and, more importantly, the reinforcing actions of psychostimulants launched the modern era of our understanding of the motivational domain of neuropsychopharmacology and served as the keystone for understanding the role of catecholamine systems in addiction. Interestingly, in the early years of the "catecholamine hypothesis of reward," Dr. Stein favored the primacy of norepinephrine (rather than dopamine) in reward processes. His laboratory showed that animals would selfadminister the dopamine agonist apomorphine, but he was at the time surprised by this finding and initially did not find it particularly compelling. In these early, heady days of neuropsychopharmacology, determining which neurotransmitter(s) had primacy in reward processes was a hot pursuit, and Dr. Stein was an able and energetic intellectual combatant. His spirited exchanges with Roy Wise, among others, who offered mounting evidence of dopamine's prominent role in reward motivation, energized the field for years, attracting investigators and stimulating research that would eventually refine the guiding hypotheses and propel the field forward.
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Dr. Stein's seminal contributions to neuropsychopharmacology extended to multiple neuropharmacological targets for systems and are now considered well established. His early pharmacological work identified GABAergic systems as the key target for the anxiolytic-like actions of benzodiazepines. He showed the first data that demonstrated the analgesic and reinforcing actions of opioid peptides in the brain. In a study that significantly influenced my own thinking, he reported seminal evidence of "opponent processing" between reward and punishment systems, the latter in the form of ascending serotonergic systems. He provided definitive evidence of a role for norepinephrine in memory consolidation. Later in his career, he and his group identified a cellular mechanism for positive reinforcement, showing that neurotransmitter systems that were hypothesized to mediate the positive reinforcing effects of psychostimulants and opioids exhibited an increase in bursting responses in hippocampal cell slice preparations. We now know that the phasic release of dopamine has powerful incentive salience properties that play a key role in motivation.
Dr. Stein had a unique talent to link his prodigious knowledge of pharmacology with sophisticated techniques in behavioral pharmacology, and this approach set the stage and opened the door to whole new domains of research in neuropharmacology. His work had a major influence on my career. Much of our early work on psychostimulants that led to identification of the role of ventral striatal dopamine in the reinforcing actions of cocaine and amphetamines was built on his seminal early contributions that linked the indirect release of catecholamines to their behavioral actions.
It is often stated that we stand on the shoulders of giants. The career of Larry Stein illustrates perhaps most dramatically how such a historical lineage evolves. His mentors were Kenneth Spence (of incentive motivation fame) and Joseph Brady (of the biology of emotion and motivation fame). Dr. Stein was a giant in our fledgling field of neuropsychopharmacology, whose work we eagerly followed for clues on how drugs worked. From this pioneer neuropsychopharmacologist, we see the roots of the modern mapping of brain circuits, not only to understand how the brain works but also to understand how it fails to work in pathological states.
Dr. Stein published extensively in top journals of the field, including 17 papers in Science and Nature, demonstrating not only the high innovativeness of his research but also its future impact. He was highly esteemed by his peers, winning the A. E. Bennett Award from the Society of Biological Psychiatry for Original Research in Neuropsychiatry. He served as President of the Division of Psychopharmacology for the American Psychological Association. He was an early member of ACNP. He was an excellent teacher and mentor and was generous with his time and wisdom. He had an exquisitely clear and precise style of scientific writing that he generously labored to pass on to his students. By all accounts, his tenure as Chair of Pharmacology at the University of California led to a dynamic forward-thinking department. He was known as a scholar, espousing that our charge in science is first and foremost an intellectual pursuit. Indeed, it is characteristic of his personality that, after retiring, he turned his insatiable curiosity toward the study of the Iliad, advancing bold new hypotheses on the identity of its author, Homer.
I met Larry Stein at the Eastern Psychological Association in the early 1970s. He was an affable "rock star" of behavioral neuroscience at the time. He heard me give my first talk at a scientific meeting, and his compliments afterward had a very positive impact that often sustained me in those early years. As many others of his generation, he remained a guardian angel-like mentor to my generation. He was known for his kindness, providing support for Dr. Marianne Olds when Jim Olds passed away. For those of us who remember Larry fondly, perhaps these were his greatest attributes-an unrelenting love of science, with high integrity, boundless enthusiasm, and generosity.
